Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCGSTRAIN IV
NCT05397678Phase 4Recruiting
- Sponsor
- Bandim Health Project
- Start
- Oct 2022
- Primary completion
- Jul 2024
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of bacillus calmette-guerin substrain danish 1331 live antigen in neonatal death, sponsored by Bandim Health Project. Started Oct 2022; status: recruiting.
02
Drugs
bacillus calmette-guerin substrain danish 1331 live antigen
03
Conditions
neonatal death
Beyond the preview
Go deeper on NCT05397678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05397678.